Skip to main content

UK researchers are launching a Phase 2 trial looking at a cannabis-based therapy for Alzheimer’s

A research team at King’s College London is launching a Phase 2 trial of a cannabis-based therapy for the treatment of certain dementia symptoms, according to a Friday announcement by Alzheimer’s Research UK, which will be funding the study.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.